Singapore markets close in 5 hours 3 minutes
Straits Times Index
3,299.69 +7.00 (+0.21%) Nikkei
38,299.25 +25.20 (+0.07%) Hang Seng
18,090.18 +327.15 (+1.84%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,475.32 -2,712.06 (-4.51%) CMC Crypto 200
1,261.77 -77.29 (-5.77%)
ABT Jun 2024 120.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:46PM EDT. Market open.
| Previous close | 11.70 |
| Open | 12.30 |
| Bid | 13.25 |
| Ask | 15.55 |
| Strike | 120.00 |
| Expiry date | 2024-06-21 |
| Day's range | 11.70 - 12.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 232 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.